A publication in the Journal of the American Academy of Dermatology highlights the improved performance of DecisionDx-SCC. This development is attributed to the integration of select clinicopathologic risk factors.

The enhanced performance of DecisionDx-SCC provides a more precise result, which can support risk-aligned patient management.

Further details about the improved performance and its implications are available from the source publication, which provides more information on this development and its potential impact on patient care.